All Pregnant Women Should Be Screened for Group B Strep

FEBRUARY 01, 2003

The American College of Obstetricians and Gynecologists has issued new recommendations calling for universal screening of pregnant women for group B streptococci. These pathogens can be passed from mother to baby during pregnancy or delivery and are a leading cause of illness and death among newborns in the United States. Antibiotic treatment during labor may prevent transmission to the newborn, however. The new recommendations reflect findings from the Centers for Disease Control and Prevention, showing routine prenatal screening to be more effective than risk-based approaches (ie, assessing clinical risk factors at the time of labor).



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.